Monday, June 30, 2025 6/30/2025

NRG Oncology NCORP Research Base

Award Number: UG1CA189867
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: COOPERATIVE AGREEMENT
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 08/01/2014
PERIOD OF PERFORMANCE END DATE: 07/31/2025

Group Awards By:

View Award Description

NRG Oncology NCORP Research Base - The objective of this proposal is to establish and maintain the NCORP (National Community Oncology Research Program) for the NRG Oncology research base. The NRG NCORP is the result of aligning the legacy CCOPs (Community Clinical Oncology Programs) from three NCI Cancer Cooperative Groups: NSABP, RTOG and GOG. These groups together have over almost 100 years of combined experience serving as CCOP Research Bases. NRG NCORP, comprised of a multi-disciplinary team of investigators and patient advocates, is poised to carry out the objectives of: 1) designing and conducting cancer prevention, control and screening clinical trials; 2) designing and embedding patient reported outcomes in both primary NCOPR trials as well as NRG therapeutic trials 3) designing and conducting cancer care delivery research; 4) enhancing community access to treatment and imaging trials conducted under the National Clinical Trials Network (NCTN) and 5) conducting primary intervention trials and integrating health disparity research questions into cancer care delivery research and treatment trials. To allow NRG NCORP to meet these goals, the group will: participate fully in NRG Oncology leadership and will determine the scientific direction and prioritization of the NRG NCORP activities and resources and oversee the translational research, clinical trial activities, and correlative studies related to the aims of NRG NCORP. With the NRG Statistical and Data Management Center (SDMC), this team will provide efficient, methodologically up-to-date trial design with a focus on NCORP specific needs such as patient-reported repeated longitudinal assessments and cluster-randomized designs. NRG NCORP will provide study monitoring, reporting, and analysis; build an infrastructure to support our cancer care delivery research agenda; provide comprehensive data management quality control and quality assurance programs to ensure high data integrity and timely data for analysis; leverage cutting edge information technology emphasizing security, timeliness, and efficiency of data collection and management; providing RT credentialing and quality assurance; and provide education and training for institutional Clinical Research Associates, Study Chairs, local Principal Investigators and others involved in the NRG NCORP research agenda. Further, to accomplish these aims NRG NCORP will engage fully with NCI-designated NCORP community physicians and patient advocates as well as the NCI and other NCI-sponsored entities (cooperative groups, cancer centers, SPOREs) to collaborate across the NCTN to improve cancer prevention and control, cancer care and outcomes, and quality of life for patients affected by cancer.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $0 )
2025	2024	NRG ONCOLOGY FOUNDATION INC	1600 JOHN F KENNEDY BLVD	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Control	000	11	3/4/2025	NON-COMPETING CONTINUATION	$0
2025	2024	NRG ONCOLOGY FOUNDATION INC	1600 JOHN F KENNEDY BLVD	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Control	001	11	4/7/2025	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2024 ( Subtotal = $11,641,986 )
2024	2024	NRG ONCOLOGY FOUNDATION INC	1600 JOHN F KENNEDY BLVD	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Control	003	11	8/1/2024	NON-COMPETING CONTINUATION	$11,641,986
2024	2023	NRG ONCOLOGY FOUNDATION INC	1600 JOHN F KENNEDY BLVD	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Control	002	10	7/3/2024	NON-COMPETING CONTINUATION	$0
2024	2023	NRG ONCOLOGY FOUNDATION INC	1600 JOHN F KENNEDY BLVD	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Control	000	10	10/23/2023	NON-COMPETING CONTINUATION	$0
2024	2023	NRG ONCOLOGY FOUNDATION INC	1600 JOHN F KENNEDY BLVD	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Control	001	10	3/14/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = $11,641,986

Issue Date FY: 2023 ( Subtotal = $10,848,989 )
2023	2023	NRG ONCOLOGY FOUNDATION INC	1600 JOHN F KENNEDY BLVD	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Control	003	10	8/1/2023	NON-COMPETING CONTINUATION	$10,848,989
2023	2022	NRG ONCOLOGY FOUNDATION INC	1600 JOHN F KENNEDY BLVD	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Control	002	9	7/13/2023	NON-COMPETING CONTINUATION	$0
2023	2022	NRG ONCOLOGY FOUNDATION, INC.	1600 JOHN F KENNEDY BLVD STE 1020	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Control	000	9	11/2/2022	NON-COMPETING CONTINUATION	$0
2023	2022	NRG ONCOLOGY FOUNDATION, INC.	1600 JOHN F KENNEDY BLVD STE 1020	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Control	001	9	12/7/2022	NON-COMPETING CONTINUATION	$0
														Subtotal = $10,848,989

Issue Date FY: 2022 ( Subtotal = $9,180,769 )
2022	2022	NRG ONCOLOGY FOUNDATION, INC.	1600 JOHN F KENNEDY BLVD STE 1020	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Control	001	9	8/26/2022	NON-COMPETING CONTINUATION	$9,180,769
2022	2021	NRG ONCOLOGY FOUNDATION, INC.	1600 JOHN F KENNEDY BLVD STE 1020	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Control	000	8	4/1/2022	NON-COMPETING CONTINUATION	$0
														Subtotal = $9,180,769

Issue Date FY: 2021 ( Subtotal = $7,347,169 )
2021	2021	NRG ONCOLOGY FOUNDATION, INC.	1600 JOHN F KENNEDY BLVD STE 1020	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Control	000	8	7/27/2021	NON-COMPETING CONTINUATION	$7,347,169
														Subtotal = $7,347,169

Issue Date FY: 2020 ( Subtotal = $11,274,429 )
2020	2020	NRG ONCOLOGY FOUNDATION, INC.	1600 JOHN F KENNEDY BLVD STE 1020	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Control	005	7	7/23/2020	NON-COMPETING CONTINUATION	$11,114,032
2020	2020	NRG ONCOLOGY FOUNDATION, INC.	1600 JOHN F KENNEDY BLVD STE 1020	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Control	007	7	9/1/2020	SUPPLEMENT FOR EXPANSION	$149,590
2020	2020	NRG ONCOLOGY FOUNDATION, INC.	1600 JOHN F KENNEDY BLVD STE 1020	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Control	006	7	8/31/2020	SUPPLEMENT FOR EXPANSION	$10,807
2020	2019	NRG ONCOLOGY FOUNDATION, INC.	1600 JOHN F KENNEDY BLVD STE 1020	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Control	002	6	3/2/2020	COMPETING CONTINUATION	$5,195,641
2020	2019	NRG ONCOLOGY FOUNDATION, INC.	1600 JOHN F KENNEDY BLVD STE 1020	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Control	004	6	7/20/2020	COMPETING CONTINUATION	-$10,046
2020	2019	NRG ONCOLOGY FOUNDATION, INC.	1600 JOHN F KENNEDY BLVD STE 1020	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Control	000	6	11/4/2019	COMPETING CONTINUATION	$0
2020	2018	NRG ONCOLOGY FOUNDATION, INC.	1600 JOHN F KENNEDY BLVD STE 1020	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	001	5	3/2/2020	NON-COMPETING CONTINUATION	-$5,195,641
2020	2018	NRG ONCOLOGY FOUNDATION, INC.	1600 JOHN F KENNEDY BLVD STE 1020	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	003	5	7/20/2020	NON-COMPETING CONTINUATION	$10,046
														Subtotal = $11,274,429

Issue Date FY: 2019 ( Subtotal = $12,780,253 )
2019	2019	NRG ONCOLOGY FOUNDATION, INC.	1600 JOHN F KENNEDY BLVD STE 1020	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Control	002	6	8/20/2019	COMPETING CONTINUATION	$12,199,117
2019	2019	NRG ONCOLOGY FOUNDATION, INC.	1600 JOHN F KENNEDY BLVD STE 1020	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Control	004	6	8/29/2019	SUPPLEMENT FOR EXPANSION	$445,671
2019	2019	NRG ONCOLOGY FOUNDATION, INC.	1600 JOHN F KENNEDY BLVD STE 1020	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Control	003	6	8/23/2019	SUPPLEMENT FOR EXPANSION	$135,465
2019	2018	NRG ONCOLOGY FOUNDATION, INC.	1600 JOHN F KENNEDY BLVD STE 1020	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	000	5	12/12/2018	NON-COMPETING CONTINUATION	$0
2019	2018	NRG ONCOLOGY FOUNDATION, INC.	1600 JOHN F KENNEDY BLVD STE 1020	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	001	5	5/22/2019	NON-COMPETING CONTINUATION	$0
														Subtotal = $12,780,253

Issue Date FY: 2018 ( Subtotal = $8,786,543 )
2018	2018	NRG ONCOLOGY FOUNDATION, INC.	1600 JOHN F KENNEDY BLVD STE 1020	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	000	5	7/30/2018	NON-COMPETING CONTINUATION	$8,598,540
2018	2018	NRG ONCOLOGY FOUNDATION, INC.	1600 JOHN F KENNEDY BLVD STE 1020	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	001	5	9/17/2018	NON-COMPETING CONTINUATION	$188,003
														Subtotal = $8,786,543

Issue Date FY: 2017 ( Subtotal = $9,187,047 )
2017	2017	NRG ONCOLOGY FOUNDATION, INC.	1600 JOHN F KENNEDY BLVD STE 1020	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	000	4	7/28/2017	NON-COMPETING CONTINUATION	$9,060,908
2017	2017	NRG ONCOLOGY FOUNDATION, INC.	1600 JOHN F KENNEDY BLVD STE 1020	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Control	001	4	9/13/2017	SUPPLEMENT FOR EXPANSION	$126,139
														Subtotal = $9,187,047

Issue Date FY: 2016 ( Subtotal = $7,442,513 )
2016	2016	NRG ONCOLOGY FOUNDATION INC	1600 JOHN F KENNEDY BOULEVARD	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	000	3	8/1/2016	NON-COMPETING CONTINUATION	$7,316,374
2016	2016	NRG ONCOLOGY FOUNDATION INC	1600 JOHN F KENNEDY BOULEVARD	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Control	001	3	8/31/2016	SUPPLEMENT FOR EXPANSION	$126,139
														Subtotal = $7,442,513

Issue Date FY: 2015 ( Subtotal = $10,675,543 )
2015	2015	NRG ONCOLOGY FOUNDATION INC	1600 JOHN F KENNEDY BOULEVARD	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Control	001	2	9/10/2015	SUPPLEMENT FOR EXPANSION	$133,139
2015	2015	NRG ONCOLOGY FOUNDATION INC	1600 JOHN F KENNEDY BOULEVARD	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	000	2	9/9/2015	NON-COMPETING CONTINUATION	$10,542,404
														Subtotal = $10,675,543

Issue Date FY: 2014 ( Subtotal = $11,185,388 )
2014	2014	NRG ONCOLOGY FOUNDATION INC	1600 JOHN F KENNEDY BOULEVARD	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	000	1	8/1/2014	NEW	$10,960,683
2014	2014	NRG ONCOLOGY FOUNDATION INC	1600 JOHN F KENNEDY BOULEVARD	PHILADELPHIA	PA	19103	PHILADELPHIA	USA	Cancer Treatment Research	001	1	9/19/2014	NEW	$224,705
														Subtotal = $11,185,388

Grand Total All Awards = $110,350,629

Top

All Categories

About

Search

Reports

Data Submission

Award Information

NRG Oncology NCORP Research Base

Award Number: UG1CA189867

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: COOPERATIVE AGREEMENT

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 08/01/2014

PERIOD OF PERFORMANCE END DATE: 07/31/2025

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer